Portfolio Company · Operating Co.

LXE Hearing

Healthcare · Website

backed byPatient Square Capital

CurrentHealthcare

LXE Hearing

a portfolio company of

Patient Square Capital

Status on record: Current

PE Firm Index

Who owns LXE Hearing?

LXE Hearing is listed as a current portfolio company of Patient Square Capital on Patient Square Capital's own portfolio page.

From the company's website

Innovative hearing aids at affordable prices with different styles from behind-the-ear to earbuds to completely-in-canal with award-winning customer support.

Source: lxehearing.com, read November 2026

Company Snapshot

LXE Hearing is a Healthcare company. Its owner on record, Patient Square Capital, is a firm. Patient Square Capital lists 18 companies in the index, 8 of them in Healthcare.

SectorHealthcare

Parent PE firmPatient Square Capital

Ownership statusCurrent

WebsiteVisit ↗

About the owner

Patient Square Capital

Companies in the index: 18

Health-care dedicated investment firm.

Read the Patient Square Capital profile

Questions about LXE Hearing

Who owns LXE Hearing?

LXE Hearing is listed as a current portfolio company of Patient Square Capital on Patient Square Capital's own portfolio page.

What sector is LXE Hearing in?

LXE Hearing is in Healthcare. Classified from the company's own description.

What else does Patient Square Capital own in Healthcare?

Patient Square Capital lists 7 other Healthcare companies in the index, including CorroHealth, Hanger, Osanni Bio, Paradigm and Patterson.

What is LXE Hearing's website?

LXE Hearing's website is https://lxehearing.com/.

Sources

Patient Square Capital's page on LXE Hearing
Patient Square Capital
https://patientsquarecapital.com/portfolio

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with LXE Hearing and does not provide investment advice.

Other portfolio companies of Patient Square Capital

6 of 17 shown

Elevage Medical Technologies

Enavate Sciences

See the full Patient Square Capital portfolio.

Other Healthcare companies held by Patient Square Capital

Radius Health Syneos Health

Other Healthcare portfolio companies

via Wavemaker 360 Health

3P Biopharmaceuticals

via Marlin Equity Partners

Browse PE-backed companies.

Is this your company?

Claiming is free and reviewed by hand. Correct facts and add your team.

Claim this profile Suggest a correction

Ownership

Parent PE firm

Patient Square Capital

Status: Current

Check this company's website

Check this company's website now

Free, in about two minutes: the verified issues a buyer or a customer's browser would meet. Runs on GTM Brain, by DevriX.

Observational measurements of this company's public website only. Not a rating of the company, its performance, its management, or its investment merit. Not investment advice. Request a correction or removal via Submit Update.

For PE-backed companies

DevriX

DevriX runs the websites, integrations and data that bring in revenue, as one accountable engineering and operations team, through acquisitions and exit.

Where DevriX helps

Value creation through the holdRevenue, data, web and AI run as one operating cadence, tied to EBITDA.Add-ons and carve-outsConsolidate or separate platforms and unify reporting after a deal.Exit readinessFind the technology and data issues a buyer's diligence would raise, before it does.

Send DevriX a short brief

A short form on devrix.com. No call to book.

Disclosure: PE Firm Index is maintained by Mario Peshev, who founded and runs DevriX. DevriX listing

Weekly PE M&A and market research, by email

The Growth Shuttle Insider is Mario Peshev's weekly newsletter for PE owners and operators. Each issue carries the week's private equity deals from this index, market data and research, and an essay from Mario.

Free. One email a week. Unsubscribe from any issue. Your address goes to beehiiv, the service that sends the Insider.

Research

The 2027 Digital Value Creation Baseline

1,407 PE-backed companies from 179 sponsors, measured from public sources in October 2026. 15% of service and product companies have the full path from search to CRM.

Read the research

Research by Growth Shuttle and DevriX.